Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry
- DOI
- 10.1080/19420862.2026.2699078
- Published
- 2026-07-15
- Container
- mAbs
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/19420862.2026.2699078,
title = {Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry},
author = {Elizabeth Hecht and Esther Martin and Idlir Liko and Andrew Mahan and Aniruddha Sahasrabuddhe and Nastaran N. Tajoddin and Iain D. G. Campuzano},
year = {2026},
journal = {mAbs},
doi = {10.1080/19420862.2026.2699078},
url = {https://doi.org/10.1080/19420862.2026.2699078}
}RIS
TY - JOUR TI - Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry AU - Elizabeth Hecht AU - Esther Martin AU - Idlir Liko AU - Andrew Mahan AU - Aniruddha Sahasrabuddhe AU - Nastaran N. Tajoddin AU - Iain D. G. Campuzano PY - 2026 JO - mAbs DO - 10.1080/19420862.2026.2699078 UR - https://doi.org/10.1080/19420862.2026.2699078 ER -
APA
Hecht, E., Martin, E., Liko, I., Mahan, A., Sahasrabuddhe, A., Tajoddin, N. N., & Campuzano, I. D. G. (2026). Setting expectations for current and future directions of native mass spectrometry in the biopharmaceutical industry. mAbs. https://doi.org/10.1080/19420862.2026.2699078
Source records
- crossref · retrieved 2026-09-25T16:33:20.139Z